Akihiro Furukawa

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 1.9

ph-index = 9

Forward Citations = 250(Granted Patents)

Location History:

Kanagawa, JP (2011)
Tokyo, JP (1986 - 2024)

Company Filing History:

Daiichi Sankyo Company, Limited

patents

1 out of 5,289

Nippon Telegraph and Telephone Corporation

patents

4. 1 out of 15,458

University of California

where one patent can have more than one assignee

Years Active: 1986-2024

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11939403 - Peptide-peptoid scaffolds (2024-03-26),

2. 11149066 - Thrombospondin 1-binding peptide (2021-10-19),

3. 8415359 - Phenylpyrrole derivative (2013-04-09),

4. 8017610 - Phenylpyrrole derivative (2011-09-13),

5. 4802006 - Signal processing unit for producing a selected one of signals (1989-01-31),

6. 4706265 - Code converting system and method for band compression of digital signals (1987-11-10),

7. 4689673 - Movement compensation predictive encoder for a moving picture signal (1987-08-25),

8. 4689672 - Method and device of coding a digital video signal for reproduction of (1987-08-25),

9. 4689671 - Coding apparatus for moving object image (1987-08-25),

10. 4683494 - Inter-frame predictive coding apparatus for video signal (1987-07-28),

11. 4668986 - Motion-adaptive interpolation method for motion video signal and device (1987-05-26),

12. 4667233 - Apparatus for discriminating a moving region and a stationary region in (1987-05-19),

13. 4575756 - Decoder for a frame or field skipped TV signal with a representative (1986-03-11),

Title: Akihiro Furukawa: Innovator in Molecular Scaffolds

Introduction

Akihiro Furukawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of molecular scaffolds, holding a total of 13 patents. His work focuses on developing innovative compounds that have the potential to impact various medical applications.

Latest Patents

Among his latest patents are the peptide-peptoid scaffolds, which include cyclic peptides that exhibit high cell permeability. Another notable invention is the thrombospondin 1-binding peptide, which promotes angiogenesis by inhibiting the function of TSP1. This compound is particularly useful for treating or preventing diseases such as critical limb ischemia. The macrocyclic polypeptide he developed is represented by a complex formula that includes various amino acid residues, showcasing his expertise in molecular design.

Career Highlights

Throughout his career, Akihiro Furukawa has worked with notable companies such as NEC Corporation and Daiichi Sankyo Company, Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of molecular biology.

Collaborations

He has collaborated with esteemed colleagues, including Junichi Ohki and Takehiro Fukuzaki. These partnerships have further enhanced his research capabilities and have led to the development of innovative solutions in his area of expertise.

Conclusion

Akihiro Furukawa's contributions to molecular scaffolds and his impressive portfolio of patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.